Filing Details
- Accession Number:
- 0001181431-14-021200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-23 19:46:11
- Reporting Period:
- 2014-05-22
- Filing Date:
- 2014-05-23
- Accepted Time:
- 2014-05-23 19:46:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585663 | P. Lawrence Wennogle | C/O Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 | Vice President, Drug Discovery | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-05-22 | 1,694 | $14.99 | 110,806 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-22 | 4,306 | $15.00 | 106,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |